Cargando…
A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux
INTRODUCTION: The healthcare sector contributes 5–8% of the global greenhouse gas emissions. Global and regional organizations and governments have started to design and implement measures to reduce global greenhouse gas emissions in the healthcare sector, e.g. by green public procurement policies a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860470/ https://www.ncbi.nlm.nih.gov/pubmed/31625130 http://dx.doi.org/10.1007/s12325-019-01114-1 |
_version_ | 1783471246309064704 |
---|---|
author | Ortsäter, Gustaf Borgström, Fredrik Soulard, Stéphane Miltenburger, Carolin |
author_facet | Ortsäter, Gustaf Borgström, Fredrik Soulard, Stéphane Miltenburger, Carolin |
author_sort | Ortsäter, Gustaf |
collection | PubMed |
description | INTRODUCTION: The healthcare sector contributes 5–8% of the global greenhouse gas emissions. Global and regional organizations and governments have started to design and implement measures to reduce global greenhouse gas emissions in the healthcare sector, e.g. by green public procurement policies and inclusion of ecological considerations in the decision-making process for purchasing and funding of healthcare technologies. The objective of this study was to perform budget impact analysis of adopting RESPIMAT re-usable in the Nordics and Benelux that considered both the traditional healthcare costs as well as the environmental impact. METHODS: Inhaler costs and environmental impact over 5 years in the Nordics and Benelux in a scenario with RESPIMAT re-usable compared to a scenario without RESPIMAT re-usable were estimated using an budget impact model. RESPIMAT re-usable enables patients to re-use the inhaler device and its availability therefore reduces the number of inhalers and associated wastage. The carbon emissions were derived for each treatment pattern considering the whole life cycle (cradle-to-grave) of the inhaler product. The cost of carbon emissions was estimated using a societal cost per ton of carbon emission. RESULTS: Progressively introducing RESPIMAT re-usable in the Nordics and Benelux was estimated to decrease the number of inhalers used by 2023 by 7,466,621 compared to a scenario without RESPIMAT re-usable, which would result in a reduction of the environmental burden of inhaler use of 4717 tCO(2)e and a decrease in societal cost of €205,888. CONCLUSIONS: Adopting RESPIMAT re-usable would lead to a substantial reduction in CO(2) emissions, leading to savings from a societal perspective. FUNDING: Boehringer Ingelheim. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12325-019-01114-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6860470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-68604702019-12-03 A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux Ortsäter, Gustaf Borgström, Fredrik Soulard, Stéphane Miltenburger, Carolin Adv Ther Original Research INTRODUCTION: The healthcare sector contributes 5–8% of the global greenhouse gas emissions. Global and regional organizations and governments have started to design and implement measures to reduce global greenhouse gas emissions in the healthcare sector, e.g. by green public procurement policies and inclusion of ecological considerations in the decision-making process for purchasing and funding of healthcare technologies. The objective of this study was to perform budget impact analysis of adopting RESPIMAT re-usable in the Nordics and Benelux that considered both the traditional healthcare costs as well as the environmental impact. METHODS: Inhaler costs and environmental impact over 5 years in the Nordics and Benelux in a scenario with RESPIMAT re-usable compared to a scenario without RESPIMAT re-usable were estimated using an budget impact model. RESPIMAT re-usable enables patients to re-use the inhaler device and its availability therefore reduces the number of inhalers and associated wastage. The carbon emissions were derived for each treatment pattern considering the whole life cycle (cradle-to-grave) of the inhaler product. The cost of carbon emissions was estimated using a societal cost per ton of carbon emission. RESULTS: Progressively introducing RESPIMAT re-usable in the Nordics and Benelux was estimated to decrease the number of inhalers used by 2023 by 7,466,621 compared to a scenario without RESPIMAT re-usable, which would result in a reduction of the environmental burden of inhaler use of 4717 tCO(2)e and a decrease in societal cost of €205,888. CONCLUSIONS: Adopting RESPIMAT re-usable would lead to a substantial reduction in CO(2) emissions, leading to savings from a societal perspective. FUNDING: Boehringer Ingelheim. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12325-019-01114-1) contains supplementary material, which is available to authorized users. Springer Healthcare 2019-10-17 2019 /pmc/articles/PMC6860470/ /pubmed/31625130 http://dx.doi.org/10.1007/s12325-019-01114-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Ortsäter, Gustaf Borgström, Fredrik Soulard, Stéphane Miltenburger, Carolin A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux |
title | A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux |
title_full | A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux |
title_fullStr | A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux |
title_full_unstemmed | A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux |
title_short | A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT(®) Re-usable in the Nordics and Benelux |
title_sort | budget impact model to estimate the environmental impact of adopting respimat(®) re-usable in the nordics and benelux |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860470/ https://www.ncbi.nlm.nih.gov/pubmed/31625130 http://dx.doi.org/10.1007/s12325-019-01114-1 |
work_keys_str_mv | AT ortsatergustaf abudgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux AT borgstromfredrik abudgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux AT soulardstephane abudgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux AT miltenburgercarolin abudgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux AT ortsatergustaf budgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux AT borgstromfredrik budgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux AT soulardstephane budgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux AT miltenburgercarolin budgetimpactmodeltoestimatetheenvironmentalimpactofadoptingrespimatreusableinthenordicsandbenelux |